Liberty Mutual Group Asset Management Inc. Bristol Myers Squibb CO Transaction History

Liberty Mutual Group Asset Management Inc.

$679 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $3.19 Million - $4.13 Million	-65,336 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $1,263 - $1,574	-25 Reduced 0.04%	65,336 $3.62 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $490,189 - $534,432	-8,178 Reduced 11.12%	65,361 $4.01 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $4.06 Million - $4.69 Million	73,539	73,539 $4.69 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.

Account